Perspective Therapeutics (CATX) Income from Continuing Operations (2010 - 2026)
Perspective Therapeutics recorded quarterly Income from Continuing Operations of 26189000.0 in Q1 2026, down 139.59% quarter-over-quarter from 66145000.0 in Q4 2025, and down 44.08% year-over-year from 46831033.25 in Q1 2025.
Perspective Therapeutics' Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 26189000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 44.08% year-over-year to 26189000.0; the TTM figure through Mar 2026 stood at 8012000.0 (up 90.72% YoY), while the FY2024 annual figure was 79989000.0, down 99.44% from the prior year.
- Income from Continuing Operations came in at 26189000.0 for Q1 2026 at Perspective Therapeutics, down from 66145000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 66145000.0 in Q4 2025 to a low of 41828000.0 in Q4 2024.
- A 5-year average of 9477176.47 and a median of 11214000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations slumped 3087.33% in 2024 and surged 258.14% in 2025, its largest moves.
- Perspective Therapeutics' Income from Continuing Operations stood at 7335000.0 in 2022, then slumped by 149.12% to 18273000.0 in 2023, then plunged by 128.91% to 41828000.0 in 2024, then soared by 258.14% to 66145000.0 in 2025, then slumped by 139.59% to 26189000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 26189000.0, 66145000.0, and 25969000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | -26.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.19 Mn |
| Dec 31, 2025 | 66.15 Mn |
| Sep 30, 2025 | -25.97 Mn |
| Jun 30, 2025 | -22.00 Mn |
| Mar 31, 2025 | -18.18 Mn |
| Dec 31, 2024 | -41.83 Mn |
| Sep 30, 2024 | -15.12 Mn |
| Jun 30, 2024 | -11.21 Mn |
| Mar 31, 2024 | -11.83 Mn |
| Dec 31, 2023 | -18.27 Mn |
| Sep 30, 2023 | -10.36 Mn |
| Jun 30, 2023 | -11.11 Mn |
| Mar 31, 2023 | -371,000.00 |
| Dec 31, 2022 | -7.34 Mn |
| Sep 30, 2022 | -4.07 Mn |
| Jun 30, 2022 | -2.08 Mn |
| Mar 31, 2022 | -1.35 Mn |
| Dec 31, 2021 | -1.60 Mn |
| Sep 30, 2021 | -2.24 Mn |
| Jun 30, 2021 | 1.35 Mn |
| Mar 31, 2021 | -745,000.00 |
| Dec 31, 2020 | -868,000.00 |
| Sep 30, 2020 | -713,000.00 |
| Jun 30, 2020 | -1.19 Mn |
| Mar 31, 2020 | -545,000.00 |
| Dec 31, 2019 | -897,000.00 |
| Sep 30, 2019 | -816,000.00 |
| Jun 30, 2019 | -1.10 Mn |
| Mar 31, 2019 | -1.13 Mn |
| Dec 31, 2018 | -1.41 Mn |
| Sep 30, 2018 | -1.51 Mn |
| Jun 30, 2018 | -2.36 Mn |
| Mar 31, 2018 | -1.33 Mn |
| Dec 31, 2017 | -1.46 Mn |
| Sep 30, 2017 | -1.55 Mn |
| Jun 30, 2017 | -1.84 Mn |
| Mar 31, 2017 | -1.36 Mn |
| Dec 31, 2016 | -1.45 Mn |
| Sep 30, 2016 | -1.55 Mn |
| Jun 30, 2016 | -1.20 Mn |
| Mar 31, 2016 | -1.27 Mn |
| Dec 31, 2015 | -1.35 Mn |
| Sep 30, 2015 | -1.04 Mn |
| Jun 30, 2015 | -1.03 Mn |
| Mar 31, 2015 | -982,158.00 |
| Dec 31, 2014 | -947,954.00 |
| Sep 30, 2014 | -1.09 Mn |
| Jun 30, 2014 | -1.31 Mn |
| Mar 31, 2014 | -988,439.00 |
| Dec 31, 2013 | -1.04 Mn |
| Sep 30, 2013 | -1.23 Mn |
| Jun 30, 2013 | -1.02 Mn |
| Mar 31, 2013 | -824,037.00 |
| Dec 31, 2012 | -1.10 Mn |
| Sep 30, 2012 | -1.12 Mn |
| Jun 30, 2012 | -995,864.00 |
| Mar 31, 2012 | -765,981.00 |
| Dec 31, 2011 | -794,745.00 |
| Sep 30, 2011 | -1.10 Mn |
| Jun 30, 2011 | -788,997.00 |
| Mar 31, 2011 | -867,265.00 |
| Dec 31, 2010 | -648,069.00 |
| Sep 30, 2010 | -871,882.00 |